Colgate-Palmolive (NYSE:CL) Shares Bought by Conning Inc.

Conning Inc. raised its position in Colgate-Palmolive (NYSE:CL) by 13.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 391,017 shares of the company’s stock after acquiring an additional 45,281 shares during the period. Conning Inc.’s holdings in Colgate-Palmolive were worth $35,547,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. D Orazio & Associates Inc. boosted its stake in Colgate-Palmolive by 3.9% in the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after acquiring an additional 108 shares in the last quarter. Fiducient Advisors LLC boosted its stake in Colgate-Palmolive by 5.2% in the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after acquiring an additional 110 shares in the last quarter. Sequoia Financial Advisors LLC boosted its stake in Colgate-Palmolive by 0.6% in the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock valued at $2,117,000 after acquiring an additional 113 shares in the last quarter. Waldron Private Wealth LLC boosted its stake in Colgate-Palmolive by 2.1% in the third quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock valued at $585,000 after acquiring an additional 118 shares in the last quarter. Finally, Commonwealth Financial Services LLC boosted its stake in Colgate-Palmolive by 4.5% in the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock valued at $247,000 after acquiring an additional 118 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 1.3 %

CL stock opened at $86.81 on Friday. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30. The firm has a 50-day simple moving average of $90.56 and a 200-day simple moving average of $96.84. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The stock has a market capitalization of $70.93 billion, a P/E ratio of 24.66, a P/E/G ratio of 3.61 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the firm earned $0.87 EPS. Equities analysts forecast that Colgate-Palmolive will post 3.74 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Wall Street Analyst Weigh In

CL has been the subject of several research reports. TD Cowen lowered their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Barclays lowered their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.